JULIANN CASTILLO: Open Payments
NPI 1396103909 · MCALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,904 in 80 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $800 · 2025 $1,904
Food & beverage: $1,904
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $361 |
| Neurocrine BioSciences, Inc. | 9 | $305 |
| Alkermes, Inc. | 5 | $300 |
| E.R. Squibb & Sons, L.L.C. | 5 | $284 |
| Otsuka America Pharmaceutical, Inc. | 13 | $261 |
| Teva Pharmaceuticals USA, Inc. | 8 | $158 |
| Collegium Pharmaceutical, Inc. | 3 | $61 |
| Lundbeck LLC | 2 | $51 |
| Corium, LLC | 2 | $30 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
Products named: VRAYLAR, INGREZZA, COBENFY, REXULTI, ARISTADA, LYBALVI, AUSTEDO XR, Jornay PM.
Industry payments across TX — which companies pay providers there.
